BREAKING: Futures Steady Heading Into Half-Day Holiday Session Today's Spotlight IBD's 12 Days of Holiday Deals (© Chris Gash) Next Data Center Roadblock For Google, Microsoft, Oracle, Meta Is On Main Street Partner Center Nike (NKE) stock advanced before the beginning of Wednesday's abridged stock market after regulatory filings showed Apple (AAPL) CEO Tim Cook purchased roughly $3 million worth of Nike shares. Cook, who currently serves as lead independent director and chair of the Nike board's compensati ...

Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the quarter, the market is more focused on the tailwind of policy easing than the headwind of weakening fundamentals, resulting in substantial gains despite stagflation emerging as a key concern. In this environment, the fund returned 1.67% (net) during the quarter, compared to 8.13% returns of the S&P 500 Index and 3.53% returns of th ...

The Strategy stock price continued its freefall this month and is now hovering at its lowest level since September last year. MSTR stock has plunged by over 70% from its highest level in 2024, even as the S&P 500 and the Nasdaq 100 indices jumped to a record high. ...

The crypto market is trading lower today, with total market capitalization slipping by 1.1% over the past 24 hours to $3.02 trillion, according to market data. The pullback comes amid broad weakness across major assets, while trading activity remains elevated, with 24-hour volume at $98.49 billion. TLDR: Crypto market cap fell 1.1% to $3.02T, with broad losses across major assets; Galaxy Research says Bitcoin has not truly cleared $100K when adjusted for inflation; BTC is consolidating near $87K, wi ...

Core Viewpoint - MAIA Biotechnology, Inc. demonstrates strong confidence in the commercial potential of ateganosine, a first-in-class anticancer treatment, as evidenced by recent stock purchases by independent directors [1][3]. Group 1: Director Investments - Three directors purchased a total of 179,737 shares and 179,737 warrants at an average price of $1.224, raising approximately $1.51 million in gross proceeds from the private placement offering [2]. - Directors and officers currently hold 5,019,857 shares, representing 13.43% of MAIA [2]. Group 2: Product Development and Trials - The initiation of a pivotal Phase 3 international trial for ateganosine has begun, with first patient dosing occurring this month [3]. - The FDA has granted Fast Track designation for ateganosine for the treatment of non-small cell lung cancer (NSCLC), indicating a high probability of regulatory approval based on statistical assessments of the trial [3]. Group 3: Mechanism of Action - Ateganosine is a telomere-targeting agent that induces telomerase-dependent DNA modification and selective cancer cell death, showing promise in advanced NSCLC treatment [4]. - The sequential treatment of ateganosine followed by PD-(L)1 inhibitors has resulted in significant tumor regression in advanced cancer models, suggesting its potential effectiveness [4]. Group 4: Company Overview - MAIA Biotechnology focuses on developing targeted immunotherapies for cancer, with ateganosine as its lead program aimed at improving treatment outcomes for patients with telomerase-positive cancer cells [5].

Core Insights - The Meridian Hedged Equity Fund reported a return of 1.67% in Q3 2025, underperforming the S&P 500 Index which returned 8.13% and the CBOE S&P 500 BuyWrite Index which returned 3.53% [1] Company Analysis: D.R. Horton, Inc. (NYSE:DHI) - D.R. Horton, Inc. is the largest homebuilder in the U.S. by volume, focusing on entry-level and first-time buyer segments [3] - The company reported a one-month return of -6.51% and a 52-week gain of 2.42%, with shares closing at $144.47 and a market capitalization of $42.194 billion on December 23, 2025 [2] - D.R. Horton demonstrated strong operational efficiency, with better-than-expected home closings and new orders, resilient gross margins, and a 2% year-over-year decline in construction costs [3] - The company raised its share repurchase guidance, indicating confidence in future cash flows [3] - Despite its potential, D.R. Horton is not among the top 30 most popular stocks among hedge funds, with 61 hedge fund portfolios holding its stock at the end of Q3, down from 64 in the previous quarter [4]

Among that group of Americans, some of the top reasons for being stressed about finances were the cost of everyday expenses (54%), low income (46%), high debt (35%), and a lack of job security (33%). The most recent Consumer Sentiment Survey from the University of Michigan also indicates that Americans are feeling worse about the economy now than they did a year ago. In December 2025, the headline index was 52.9, down more than 28% from a year earlier. Key Takeaways 2025 was a year of change for the U.S. ec ...

Key Takeaways The rise and subsequent retreat of bitcoin perfectly encapsulates the crypto industry's year. It won big—but it doesn't have much to show for it yet. The price of bitcoin, the world's most well-known cryptocurrency, soared above $126,000, a record, but those gains evaporated and it's poised to finish down for 2025. The industry welcomed the passage of stablecoin legislation, eased regulation, and the proliferation of new ways to buy in, but by many measures it has yet to reap the benefits. Des ...

Key Takeaways The Social Security Administration follows a general schedule for mailing out checks to its more than 74 million beneficiaries. March April Most beneficiaries are paid according to their birth date and typically receive their payments on the second, third, or fourth Wednesday of each month. Those who began receiving retirement, spousal, or survivor benefits before May 1997 will typically receive their payments on the third of every month. Supplemental Security Income (SSI), a program that prov ...

Key Takeaways It was a rollercoaster of a year on Wall Street. Most experts think the ride isn't over. The S&P 500 is on track to post its third consecutive year of double-digit gains, putting the benchmark index up more than 90% since the current bull market started in October 2022. Strategists expect 2026 to be another good—if more modestly so—year for the stock market. As of mid-December, the average 2026 year-end S&P 500 price target was 7,269, according to an LPL Financial analysis. That implies about ...